The healthcare system of the United States can be seen as a complete opposite spectrum compared to the Taiwan healthcare system. Taiwan’s healthcare system focuses on providing medical help at lower costs for the current population at a high-speed rate. Whereas the United
States is looking at providing medical assist at higher costs with the most current and higher cost medical technology. In this context, what can we define as the biggest difference between the two systems? At the same time, what are the pros and cons of each system?
In addition, we are also going to look at how new digital innovations has taken each healthcare
system so far in the current society. What kind of digital innovation techniques has the Taiwan medical system been implementing compared to the United States? Based on a specific case regarding an international pharmaceutical company, we can take a closer look at how exactly new
digital techniques has taken revolution from the past until now.

Abutaleb, Yasmeen.(2018), “U.S. healthcare spending to climb 5.3 percent in 2018: agency,” Health News, https://www.reuters.com/article/us-usa-healthcare-spending/ushealthcare-spending-to-climb-53-percent-in-2018-agency-idUSKCN1FY2ZD

Ajit, Kumar. Sanjeev, Maskara.(2015), “U.S. versus Taiwan Healthcare System Reforms: What Can India Learn from them,” American Journal of Industrial and Business Management, Vol.5, 119-144.

Amadeo, Kimberly.(2019), “The Rising Cost of health Care by Year and Its Causes,” The Balance, https://www.thebalance.com/causes-of-rising-healthcare-costs-4064878

Camillo, Cheryl.(2016), “The U.S. Healthcare System: Complex and Unequal,” Global Social Welfare, Vol.3, No.2

Chakravarty, Sudeep.(2019), “World’s Top 10 Pharmaceutical Companies by Revenue,”Market Research Reports, https://www.marketresearchreports.com/blog/2019/01/30/world%E2%80%99s-top-10-pharmaceutical-companies-revenue

Cheng, Tsung-Mei.(2019), “Health Care Spending In the US and Taiwan: A Response To It’s Still the Prices, Stupid, And A Tribute To Uwe Reinhardt,” Health Affairs Blog, https://www.healthaffairs.org/do/10.1377/hblog20190206.305164/full/

Cohen, Jessica.(2018), “Amazon, Merck, Accenture to launch data-driven drug development platform,” Becker’s Hospital Review, https://www.beckershospitalreview.com/supply-chain/amazon-merck-accenture-to-launch-datadriven-drug-development-platform.html

Devine, T.(2017), “Merck & Co. is working with Amazon Web Services (AWS) to explore the creation and delivery of digital initiatives for people living with chronic disease by using Amazon Lex, the deep learning technologies that power Amazon Alexa. (TECH Talk),” Chain Drug Review, Vol.39, No.9, 53.

Dirngal, Andreas. Cocoli, Myrvet.(2016), “Global Generic Pharmaceutical Industry Review,” CRD-Healthcare, https://www.krungsri.com/bank/getmedia/a5599675-701b-49d8-a857-33d247c773a0/BTMU-Research-201602-29.aspx

Ellis, Monique.(2019), “Top 10 pharmaceutical companies in 2019,” Proclinical, https://www.proclinical.com/blogs/2019-3/the-top-10-pharmaceutical-companies-in-the-world-2019

Frakt, Austin. Carroll, Aaron.(2013), “The Quality Imperative A Commentary on theU.S. Healthcare System,” American Journal of Preventive Medicine, Vol.44, No.1S1, S22-S26.

Ho, Cai-Wei.(2018), “A Study on the Operation Strategies of Prescription Generic Firms-A case study of S Company,” http://ntcuir.ntcu.edu.tw/bitstream/987654321/13414/2/NEM105108.pdf

Kamangar, F. Millsop, JW. Tsai, D.(2015), “What can U.S. dermatology learn from health care systems abroad? An observation of Taiwan’s system of clinical efficiency as a possible model for increased patient access to care and affordability,” Dermatol Online J, Vol.21, No.5

Kaiser, Henry.(2018), “Key Facts about the Uninsured Population,” KFF, https://www.kff.org/uninsured/fact-sheet/key-facts-about-the-uninsured-population/

Kasi, Adam.(2017), “Porter Five Forces Analysis of US Pharmaceutical Industry,”Industries, https://www.porteranalysis.com/porter-five-forces-analysis-of-us-pharmaceuticalindustry/

Leonard, Kwok-han.(2013), “Drug makers are the midst of a digital revolution: pharmaceutical firms are sharpening their focus on multichannel marketing and analytics,” CRM Magazine, Vol.17, No.7, 22.

Madisha, Lusi.(2018), “Difference between Qualitative Analysis and Quantitative Anaylsis,” Difference Between.net, http://www.differencebetween.net/science/differencebetween-qualitative-analysis-and-quantitative-analysis/

Manz, Christopher. Ross, Joseph. Grande, David.(2014), “Marketing to Physicians in a Digital World,” The New England Journal of Medicine, Vol.371, 1857-1859.

Membrillo, Alex.(2019), “Healthcare Digital Marketing Trends to Expect in 2019,” Cardinal, https://www.cardinaldigitalmarketing.com/blog/healthcare-digital-marketing-trendsinnovations-seo-ppc-2019/

Merck.(2018), “Redefining Health Care with Digital Innovation,”https://www.merck.com/about/featured-stories/austin.html

Nathan, Jay. Venkatatraman, Ray.(1999), “Management of quality, capacity, and productivity at Merck.” Hospital Materiel Management Quarterly, Vol.20, No.3, 64.

Porter, Michael.(1979), “How Competitive Forces Shape Strategy,” Harvard Business Review, Vol.57, 137-145

Puhl, N. Woulfe, J. “Healthcare Sector Report.AMP,” http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=13208

Rau, Hsiao-Hsien. Hsu, Chien-Yeh.(2010), “Developing electronic health records in Taiwan,” IT professional, Vol.12, 17-25

Sands, Rory.(2013), “Porters 5 Forces-Pharmaceutical Industry,” https://prezi.com/h5l8wrg2f6rr/porters-5-forces-pharmaceutical-industry/

Sharma, Ankit.(2018), “Role of Digital Marketing in Healthcare Industry,” AeroLeads, https://aeroleads.com/blog/role-digital-marketing-health-care-industry/

Wang, Guang-Xu.(2012), “A network approach for researching political feasibility of healthcare reform: The case of universal healthcare system in Taiwan,” Social Science & Medicine, Vol.75, 2337-2344.

Whiteside, Eric.(2016), “The Industry Handbook: Pharma Industry,” Investopedia, https://www.investopedia.com/articles/markets/051316/industry-handbook-pharma-industry.asp